A recent clinical trial has raised concerns about a possible link between Medtronic’s Infuse Bone Graft and an increased risk of cancer. According to a November 2011 New York Times article, in 2011, Medtronic sought approval to market a high-strength version of its already-approved Infuse bone graft called Amplify. Amplify, which was rejected by the FDA due to significantly higher numbers of cancers in clinical trials, contains rhBMP-2, the same active ingredient in Infuse.
Off-Label Use of Infuse Similar to FDA-Rejected Drug
Although the FDA rejected Medtronic’s Amplify, the Medtronic-sponsored clinical trial results have potential implications for patients who received the Infuse bone graft. Many surgeons have administered Infuse off-label at significantly higher levels that may even exceed the amount of the protein found in Amplify. Patients who have developed cancer due to the Infuse bone graft may be entitled to compensation through a lawsuit against Medtronic.
The defective drug lawyers at Estey Bomberger are investigating potential lawsuits on behalf of anyone who was diagnosed with cancer after treatment with Medtronic Infuse for degenerative disc disease. People who received Infuse may be at higher risk for all types of cancers, including pancreatic, breast, stomach, ovarian, lung, prostate, lymphoma and skin cancers. If you or someone you care about has developed cancer after receiving a Medtronic Infuse bone graft surgery, contact Estey Bomberger today for a free consultation.
Types of Damages You May Recover
Your time to file a product liability claims for a dangerous medical device is subject to strict time limits. Call the Medtronic bone graft cancer attorneys at Estey Bomberger today to begin protecting your rights to recover the maximum financial compensation you deserve. Damages obtained in a bone graft cancer lawsuit may include:
- Medical care costs
- Lost earnings
- Loss of earning capacity
- Pain and suffering
- Wrongful death.
Experience to Get You Results
The dangerous product lawyers at Estey Bomberger have recovered millions for victims of defective products, including Medtronic medical devices. Our attorneys understand how important your claim is to your future, and will fight to recover the full and fair compensation you are entitled to. With more than 70 years of collective experience, we have the knowledge, skills, and resources to pursue litigation against this major medical device manufacturer, and will promptly bring your case to trial, if a fair settlement cannot be reached. Under our contingency fee agreement, we are only paid for our services if and when we recover compensation for you. Contact us today to speak with an Infuse bone graft lawyer at Estey Bomberger about your potential Medtronic cancer lawsuit.